These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 26616030)

  • 21. Comparison of long-term clinical outcomes between revascularization versus medical treatment in patients with silent myocardial ischemia.
    Choi KH; Lee JM; Park I; Kim J; Rhee TM; Hwang D; Park J; Park TK; Yang JH; Song YB; Hahn JY; Jeong DS; Cho YH; Kim WS; Sung K; Jang MJ; Sung JD; Choi JH; Choi SH; Koo BK; Lee YT; Kim EK; Chang SA; Park SJ; Choi JO; Lee SC; Park SW; Cho YS; Choi JY; Gwon HC; Oh JK
    Int J Cardiol; 2019 Feb; 277():47-53. PubMed ID: 30093138
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predicting the Benefits of Percutaneous Coronary Intervention on 1-Year Angina and Quality of Life in Stable Ischemic Heart Disease: Risk Models From the COURAGE Trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation).
    Zhang Z; Jones P; Weintraub WS; Mancini GBJ; Sedlis S; Maron DJ; Teo K; Hartigan P; Kostuk W; Berman D; Boden WE; Spertus JA
    Circ Cardiovasc Qual Outcomes; 2018 May; 11(5):e003971. PubMed ID: 29752388
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-Term Clinical Outcomes Following Revascularization in High-Risk Coronary Anatomy Patients With Stable Ischemic Heart Disease.
    Bainey KR; Alemayehu W; Welsh RC; Kumar A; King SB; Kirtane AJ
    J Am Heart Assoc; 2021 Jan; 10(1):e018104. PubMed ID: 33342230
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Revascularization versus medical therapy in patients aged 80 and older with stable ischemic heart disease.
    Phan DQ; Zadegan R; Lee MS
    J Am Geriatr Soc; 2021 Dec; 69(12):3457-3467. PubMed ID: 34363216
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Percutaneous coronary intervention versus coronary artery bypass graft surgery for patients with medically refractory myocardial ischemia and risk factors for adverse outcomes with bypass: a multicenter, randomized trial. Investigators of the Department of Veterans Affairs Cooperative Study #385, the Angina With Extremely Serious Operative Mortality Evaluation (AWESOME).
    Morrison DA; Sethi G; Sacks J; Henderson W; Grover F; Sedlis S; Esposito R; Ramanathan K; Weiman D; Saucedo J; Antakli T; Paramesh V; Pett S; Vernon S; Birjiniuk V; Welt F; Krucoff M; Wolfe W; Lucke JC; Mediratta S; Booth D; Barbiere C; Lewis D;
    J Am Coll Cardiol; 2001 Jul; 38(1):143-9. PubMed ID: 11451264
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Angiography-guided Multivessel Percutaneous Coronary Intervention Versus Ischemia-guided Percutaneous Coronary Intervention Versus Medical Therapy in the Management of Significant Disease in Non-Infarct-related Arteries in ST-Elevation Myocardial Infarction Patients With Multivessel Coronary Disease.
    Perera D; Crake T; Lee V
    Crit Pathw Cardiol; 2018 Jun; 17(2):77-82. PubMed ID: 29768315
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Implications of the Landmark ISCHEMIA Trial on the Initial Management of High-Risk Patients with Stable Ischemic Heart Disease.
    Vafaei P; Naderi S; Ambrosy AP; Slade JJ
    Curr Atheroscler Rep; 2021 Sep; 23(11):70. PubMed ID: 34468881
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of Patients Undergoing Percutaneous Coronary Intervention in Contemporary U.S. Practice With ISCHEMIA Trial Population.
    Chatterjee S; Fanaroff AC; Parzynski C; Curtis J; Kolansky DM; Maddox TM; Mukherjee D; Yeh RW; Giri J
    JACC Cardiovasc Interv; 2021 Nov; 14(21):2344-2349. PubMed ID: 34736733
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical Implications of the ISCHEMIA Trial: Invasive vs Conservative Approach in Stable Coronary Disease.
    Choudhary J; Chiu S; Bhugra P; Bikdeli B; Supariwala A; Jauhar R; Chatterjee S
    Curr Cardiol Rep; 2021 Mar; 23(5):43. PubMed ID: 33704597
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intravascular ultrasound to guide percutaneous coronary interventions: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(12):1-97. PubMed ID: 23074482
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association between appropriateness of coronary revascularization and quality of life in patients with stable ischemic heart disease.
    Wijeysundera HC; Qiu F; Fefer P; Bennell MC; Austin PC; Ko DT
    BMC Cardiovasc Disord; 2014 Oct; 14():137. PubMed ID: 25280534
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Myocardial Infarction in the ISCHEMIA Trial: Impact of Different Definitions on Incidence, Prognosis, and Treatment Comparisons.
    Chaitman BR; Alexander KP; Cyr DD; Berger JS; Reynolds HR; Bangalore S; Boden WE; Lopes RD; Demkow M; Piero Perna G; Riezebos RK; McFalls EO; Banerjee S; Bagai A; Gosselin G; O'Brien SM; Rockhold FW; Waters DD; Thygesen KA; Stone GW; White HD; Maron DJ; Hochman JS;
    Circulation; 2021 Feb; 143(8):790-804. PubMed ID: 33267610
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ischemia change in stable coronary artery disease is an independent predictor of death and myocardial infarction.
    Farzaneh-Far A; Phillips HR; Shaw LK; Starr AZ; Fiuzat M; O'Connor CM; Sastry A; Shaw LJ; Borges-Neto S
    JACC Cardiovasc Imaging; 2012 Jul; 5(7):715-24. PubMed ID: 22789940
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ischemia Trial: Does the Cardiology Community Need to Pivot or Continue Current Practices?
    Jafary FH; Jafary AH
    Curr Cardiol Rep; 2022 Aug; 24(8):1059-1068. PubMed ID: 35653055
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Impact of the ISCHEMIA Trial on Clinical Practice: an Interventionist's Perspective.
    Mavromatis K; Gershlick A
    Cardiovasc Drugs Ther; 2022 Oct; 36(5):1019-1026. PubMed ID: 34324117
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Economic evaluation of different treatment strategies in patients with stable angina pectoris or asymptomatic myocardial ischemia on basis of results from the Asymptomatic-Cardiac-Ischemia Pilot study (ACIP)].
    Szucs TD; Schwenkglenks M; Rutishauser W
    Med Klin (Munich); 2000 Jan; 95(1):1-13. PubMed ID: 10668338
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Revascularization vs. Medical Therapy in Stable Ischemic Heart Disease.
    Weiss S; Weintraub W
    Prog Cardiovasc Dis; 2015; 58(3):299-305. PubMed ID: 26206111
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surgical revascularization is associated with maximal survival in patients with ischemic mitral regurgitation: a 20-year experience.
    Castleberry AW; Williams JB; Daneshmand MA; Honeycutt E; Shaw LK; Samad Z; Lopes RD; Alexander JH; Mathew JP; Velazquez EJ; Milano CA; Smith PK
    Circulation; 2014 Jun; 129(24):2547-56. PubMed ID: 24744275
    [TBL] [Abstract][Full Text] [Related]  

  • 39. API expert consensus document on management of ischemic heart disease.
    Association of Physicians of India
    J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Revascularization or Optimal Medical Therapy for Stable Ischemic Heart Disease: A Bayesian Meta-Analysis of Contemporary Trials.
    Kumar A; Doshi R; Khan SU; Shariff M; Baby J; Majmundar M; Kanaa'N A; Hedrick DP; Puri R; Reed G; Mehran R; Kapadia S; Khot UN; Kalra A
    Cardiovasc Revasc Med; 2022 Jul; 40():42-47. PubMed ID: 35210188
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.